Unknown OBSERVATIONAL NCT04426084

Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study

Cardiovascular Disease, Cardiovascular Risk Factors, Treatments and Severe COVID-19 Outcomes. A Nationwide Registry-based Case-Control Study

Sponsor: Karolinska Institutet

Conditions COVID-19

Interventions Antihypertensive Agents Chronic kidney disease Diabetes type 2 Hypertension Obesity Statins (Cardiovascular Agents)

Updated 6 times since 2020 Last updated: Jul 27, 2022 Started: Mar 1, 2020 Primary completion: Jun 8, 2021 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on COVID-19, this trial is ongoing. The trial is conducted by Karolinska Institutet and has accumulated 6 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Aug 2024 — Sep 2024 [monthly]

Unknown

Status: Active Not Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Active Not Recruiting
Sep 2022 — Jul 2024 [monthly]

Active Not Recruiting
Jan 2021 — Sep 2022 [monthly]

Active Not Recruiting

▶ Show 1 earlier version

Jul 2020 — Jan 2021 [monthly]

Active Not Recruiting

First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karolinska Institutet

Data source: Karolinska Institutet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stockholm, Sweden